CRAIG PETERS: Open Payments
NPI 1851486138 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,122 in 60 payments from 19 companies in 2025. Trend: 2023 $390 · 2024 $859 · 2025 $1,122
Food & beverage: $1,122
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $171 |
| Novo Nordisk Inc | 8 | $137 |
| Lilly USA, LLC | 7 | $119 |
| Novartis Pharmaceuticals Corporation | 5 | $117 |
| SANOFI-AVENTIS U.S. LLC | 5 | $98 |
| PFIZER INC. | 5 | $83 |
| Astellas Pharma US Inc | 2 | $58 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| ABBVIE INC. | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
Products named: LEQVIO, TZIELD, MOUNJARO, EVENITY, Wegovy, OTEZLA, Veozah, ELIQUIS.
Industry payments across GA — which companies pay providers there.
